New Key Statistics Module, Z-Score and F-Score
NAS:GENE Key Ratios
Market Cap $ M | 4.51 |
Enterprise Value $ M | 2.25 |
P/E(ttm) | 1.54 |
PE Ratio without NRI | 1.16 |
Forward PE Ratio | -- |
Price/Book | 1.76 |
Price/Sales | 0.86 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 5.00 |
EPS (TTM) $ | 0.97 |
Beneish M-Score | -2.05 |
10-y EBITDA Growth Rate % | 27.80 |
5-y EBITDA Growth Rate % | 20.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.32 |
EV-to-EBITDA | -0.34 |
PEG | 0.06 |
Shares Outstanding M | 3.22 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 1.55 |
Current Ratio | 1.67 |
ROA % (ttm) | -- |
ROE % (ttm) | -- |
ROIC % (ttm) | -- |
Dividend Yield % | -- |
Altman Z-Score | -- |
GENE Number of Guru Trades
GENE Volume of Guru Trades
Gurus Latest Trades with NAS:GENE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GENE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Genetic Technologies Ltd Insider Transactions
No Available Data
News about NAS:GENE
Total 0- 1